

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 7.12501362 |
| 2 | neuron cell-cell adhesion (GO:0007158) | 6.21293338 |
| 3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.70351406 |
| 4 | nucleobase catabolic process (GO:0046113) | 5.67066051 |
| 5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.34482241 |
| 6 | ATP synthesis coupled proton transport (GO:0015986) | 5.34482241 |
| 7 | vocalization behavior (GO:0071625) | 5.14439264 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 4.92674729 |
| 9 | auditory behavior (GO:0031223) | 4.90159361 |
| 10 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.88158353 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.57723276 |
| 12 | protein localization to synapse (GO:0035418) | 4.56598866 |
| 13 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.46823560 |
| 14 | sequestering of actin monomers (GO:0042989) | 4.46194518 |
| 15 | positive regulation of synapse assembly (GO:0051965) | 4.36669751 |
| 16 | neuron recognition (GO:0008038) | 4.32814797 |
| 17 | response to histamine (GO:0034776) | 4.21533971 |
| 18 | presynaptic membrane assembly (GO:0097105) | 4.16721465 |
| 19 | gamma-aminobutyric acid transport (GO:0015812) | 4.15502746 |
| 20 | respiratory electron transport chain (GO:0022904) | 4.14663416 |
| 21 | neurofilament cytoskeleton organization (GO:0060052) | 4.13502730 |
| 22 | establishment of mitochondrion localization (GO:0051654) | 4.12713044 |
| 23 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.06686358 |
| 24 | dopamine biosynthetic process (GO:0042416) | 4.05424634 |
| 25 | electron transport chain (GO:0022900) | 4.04211925 |
| 26 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.02728699 |
| 27 | mating behavior (GO:0007617) | 3.93919403 |
| 28 | negative regulation of microtubule polymerization (GO:0031115) | 3.93152065 |
| 29 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.93147449 |
| 30 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.92540754 |
| 31 | mechanosensory behavior (GO:0007638) | 3.86966258 |
| 32 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.84854682 |
| 33 | behavioral response to nicotine (GO:0035095) | 3.84850862 |
| 34 | presynaptic membrane organization (GO:0097090) | 3.80547329 |
| 35 | dopamine transport (GO:0015872) | 3.79231709 |
| 36 | chaperone-mediated protein transport (GO:0072321) | 3.78983180 |
| 37 | response to auditory stimulus (GO:0010996) | 3.77559933 |
| 38 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.76144009 |
| 39 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.74829776 |
| 40 | behavioral response to cocaine (GO:0048148) | 3.71746797 |
| 41 | regulation of catecholamine metabolic process (GO:0042069) | 3.66013369 |
| 42 | regulation of dopamine metabolic process (GO:0042053) | 3.66013369 |
| 43 | axonal fasciculation (GO:0007413) | 3.64782285 |
| 44 | glutamate receptor signaling pathway (GO:0007215) | 3.63483497 |
| 45 | neural tube formation (GO:0001841) | 3.61872435 |
| 46 | neuron-neuron synaptic transmission (GO:0007270) | 3.58509042 |
| 47 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.58501473 |
| 48 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.58501473 |
| 49 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.58257893 |
| 50 | regulation of protein kinase A signaling (GO:0010738) | 3.57009876 |
| 51 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.56768369 |
| 52 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.55598692 |
| 53 | neurotransmitter secretion (GO:0007269) | 3.54506853 |
| 54 | dendritic spine morphogenesis (GO:0060997) | 3.47840121 |
| 55 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.46113461 |
| 56 | postsynaptic membrane organization (GO:0001941) | 3.45963989 |
| 57 | glutamate secretion (GO:0014047) | 3.44568757 |
| 58 | neuronal action potential (GO:0019228) | 3.44511508 |
| 59 | membrane hyperpolarization (GO:0060081) | 3.41458219 |
| 60 | positive regulation of amino acid transport (GO:0051957) | 3.41064245 |
| 61 | opioid receptor signaling pathway (GO:0038003) | 3.38077470 |
| 62 | neuronal action potential propagation (GO:0019227) | 3.36581821 |
| 63 | glycosphingolipid biosynthetic process (GO:0006688) | 3.33950205 |
| 64 | righting reflex (GO:0060013) | 3.33621331 |
| 65 | regulation of synapse assembly (GO:0051963) | 3.32180079 |
| 66 | limb bud formation (GO:0060174) | 3.31171357 |
| 67 | synaptic transmission, dopaminergic (GO:0001963) | 3.30912216 |
| 68 | response to cocaine (GO:0042220) | 3.28851284 |
| 69 | regulation of postsynaptic membrane potential (GO:0060078) | 3.24261221 |
| 70 | neurotransmitter transport (GO:0006836) | 3.23805018 |
| 71 | catecholamine transport (GO:0051937) | 3.23346992 |
| 72 | synapse assembly (GO:0007416) | 3.21523951 |
| 73 | synaptic vesicle endocytosis (GO:0048488) | 3.20327107 |
| 74 | regulation of synapse structural plasticity (GO:0051823) | 3.19106851 |
| 75 | response to pheromone (GO:0019236) | 3.18923658 |
| 76 | startle response (GO:0001964) | 3.17919027 |
| 77 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.17118927 |
| 78 | regulation of vesicle fusion (GO:0031338) | 3.15598563 |
| 79 | synaptic transmission, glutamatergic (GO:0035249) | 3.14132570 |
| 80 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.12582227 |
| 81 | synaptic vesicle maturation (GO:0016188) | 3.11072217 |
| 82 | sympathetic nervous system development (GO:0048485) | 3.10653664 |
| 83 | hydrogen ion transmembrane transport (GO:1902600) | 3.09676442 |
| 84 | regulation of neurotransmitter levels (GO:0001505) | 3.09112169 |
| 85 | protein neddylation (GO:0045116) | 3.08299361 |
| 86 | establishment of synaptic vesicle localization (GO:0097480) | 3.07450605 |
| 87 | synaptic vesicle transport (GO:0048489) | 3.07450605 |
| 88 | exploration behavior (GO:0035640) | 3.07310461 |
| 89 | regulation of respiratory system process (GO:0044065) | 3.07228194 |
| 90 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.06462625 |
| 91 | mitochondrion transport along microtubule (GO:0047497) | 3.06462625 |
| 92 | regulation of synaptic vesicle transport (GO:1902803) | 3.06420506 |
| 93 | dendrite morphogenesis (GO:0048813) | 3.06252287 |
| 94 | innervation (GO:0060384) | 3.05896034 |
| 95 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 3.05274381 |
| 96 | nonmotile primary cilium assembly (GO:0035058) | 3.04973002 |
| 97 | regulation of glutamate secretion (GO:0014048) | 3.03724766 |
| 98 | detection of calcium ion (GO:0005513) | 3.03289162 |
| 99 | positive regulation of synapse maturation (GO:0090129) | 3.02280237 |
| 100 | transferrin transport (GO:0033572) | 3.02126506 |
| 101 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.01413511 |
| 102 | cell migration in hindbrain (GO:0021535) | 3.01260306 |
| 103 | dendrite development (GO:0016358) | 2.98637979 |
| 104 | reflex (GO:0060004) | 2.97033156 |
| 105 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.96972968 |
| 106 | fear response (GO:0042596) | 2.96503537 |
| 107 | protein localization to cilium (GO:0061512) | 2.94777983 |
| 108 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.93722379 |
| 109 | behavioral fear response (GO:0001662) | 2.92156198 |
| 110 | behavioral defense response (GO:0002209) | 2.92156198 |
| 111 | layer formation in cerebral cortex (GO:0021819) | 2.91954623 |
| 112 | glial cell proliferation (GO:0014009) | 2.90531461 |
| 113 | behavioral response to ethanol (GO:0048149) | 2.88654608 |
| 114 | ATP biosynthetic process (GO:0006754) | 2.88454126 |
| 115 | transmission of nerve impulse (GO:0019226) | 2.88237421 |
| 116 | locomotory exploration behavior (GO:0035641) | 2.88164632 |
| 117 | regulation of synapse organization (GO:0050807) | 2.88159462 |
| 118 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.87780750 |
| 119 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.85100231 |
| 120 | central nervous system neuron axonogenesis (GO:0021955) | 2.84921409 |
| 121 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.84384445 |
| 122 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.84356536 |
| 123 | social behavior (GO:0035176) | 2.84219747 |
| 124 | intraspecies interaction between organisms (GO:0051703) | 2.84219747 |
| 125 | membrane depolarization (GO:0051899) | 2.84147604 |
| 126 | positive regulation of membrane potential (GO:0045838) | 2.83353266 |
| 127 | neurotransmitter catabolic process (GO:0042135) | 2.82769104 |
| 128 | ferric iron transport (GO:0015682) | 2.82133588 |
| 129 | positive regulation of action potential (GO:0045760) | 2.82115011 |
| 130 | regulation of action potential (GO:0098900) | 2.81489222 |
| 131 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.79155122 |
| 132 | cornea development in camera-type eye (GO:0061303) | 2.78327567 |
| 133 | regulation of dopamine secretion (GO:0014059) | 2.77715184 |
| 134 | adult walking behavior (GO:0007628) | 2.77125429 |
| 135 | prepulse inhibition (GO:0060134) | 2.74798610 |
| 136 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.74664607 |
| 137 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.74664607 |
| 138 | short-term memory (GO:0007614) | 2.72875125 |
| 139 | regulation of feeding behavior (GO:0060259) | 2.71766274 |
| 140 | response to dietary excess (GO:0002021) | 2.70973211 |
| 141 | membrane depolarization during action potential (GO:0086010) | 2.68342059 |
| 142 | somite development (GO:0061053) | 2.67830135 |
| 143 | spinal cord development (GO:0021510) | 2.67378867 |
| 144 | retinal ganglion cell axon guidance (GO:0031290) | 2.66676986 |
| 145 | synapse organization (GO:0050808) | 2.63666985 |
| 146 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.63611020 |
| 147 | organelle transport along microtubule (GO:0072384) | 2.61725275 |
| 148 | adult behavior (GO:0030534) | 2.60099871 |
| 149 | hippocampus development (GO:0021766) | 2.59388178 |
| 150 | response to amphetamine (GO:0001975) | 2.58847264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.93388167 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.94137270 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02461466 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.98448242 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.96835859 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.87861578 |
| 7 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.72374062 |
| 8 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.61289434 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.54805366 |
| 10 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.52374647 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.52276538 |
| 12 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.49287948 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46512039 |
| 14 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.46189735 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.45640788 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.45640788 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.41316958 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.40389448 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.39413732 |
| 20 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.38917784 |
| 21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.32822966 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.15299831 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.13179382 |
| 24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.12438826 |
| 25 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.10960418 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.08858482 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02802005 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.01085103 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.97364197 |
| 30 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.96989259 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.93687875 |
| 32 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.93618099 |
| 33 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.90629537 |
| 34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.90149941 |
| 35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.87785097 |
| 36 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.84893232 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84836857 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82201413 |
| 39 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.78168399 |
| 40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.77211991 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.76761709 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.74274095 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.71676628 |
| 44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66187795 |
| 45 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.60887244 |
| 46 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.53054041 |
| 47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.48058521 |
| 48 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.47386828 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45688573 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41547260 |
| 51 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.40219462 |
| 52 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39598596 |
| 53 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37272049 |
| 54 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.37251793 |
| 55 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.36435513 |
| 56 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.35739477 |
| 57 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.35263277 |
| 58 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34263062 |
| 59 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.33604665 |
| 60 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.33117806 |
| 61 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.31402369 |
| 62 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.31402369 |
| 63 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31394528 |
| 64 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28738378 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24351962 |
| 66 | JUN_21703547_ChIP-Seq_K562_Human | 1.22082210 |
| 67 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.20635854 |
| 68 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20154758 |
| 69 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18858781 |
| 70 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18297554 |
| 71 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17818022 |
| 72 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.17425082 |
| 73 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.15849127 |
| 74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14577672 |
| 75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.14254452 |
| 76 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12351647 |
| 77 | EWS_26573619_Chip-Seq_HEK293_Human | 1.11056779 |
| 78 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.10598748 |
| 79 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.10332096 |
| 80 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10332096 |
| 81 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07600343 |
| 82 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06776927 |
| 83 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06716821 |
| 84 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06509631 |
| 85 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06280128 |
| 86 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04256976 |
| 87 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.04171680 |
| 88 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03780795 |
| 89 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.02665315 |
| 90 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02457941 |
| 91 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00424606 |
| 92 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00421727 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00389028 |
| 94 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00347112 |
| 95 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.00152455 |
| 96 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99034421 |
| 97 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98955012 |
| 98 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97714738 |
| 99 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.97662415 |
| 100 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.97333269 |
| 101 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96790470 |
| 102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96659149 |
| 103 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94934473 |
| 104 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.94682254 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94481644 |
| 106 | KDM2B_26808549_Chip-Seq_REH_Human | 0.94111605 |
| 107 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.93800220 |
| 108 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91546852 |
| 109 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.91206179 |
| 110 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.89569010 |
| 111 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.88933789 |
| 112 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.86698978 |
| 113 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86473682 |
| 114 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.85498482 |
| 115 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.85289170 |
| 116 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.85033107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.21134649 |
| 2 | MP0006276_abnormal_autonomic_nervous | 3.82860958 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.52695154 |
| 4 | MP0001529_abnormal_vocalization | 3.42141457 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.32640966 |
| 6 | MP0009046_muscle_twitch | 2.98553868 |
| 7 | MP0009745_abnormal_behavioral_response | 2.92826303 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.87871501 |
| 9 | MP0002064_seizures | 2.81501040 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.78884651 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.78619931 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.65235076 |
| 13 | MP0001440_abnormal_grooming_behavior | 2.50613011 |
| 14 | MP0003122_maternal_imprinting | 2.50141055 |
| 15 | MP0001905_abnormal_dopamine_level | 2.47327500 |
| 16 | MP0004270_analgesia | 2.42057874 |
| 17 | MP0002272_abnormal_nervous_system | 2.37901103 |
| 18 | MP0002736_abnormal_nociception_after | 2.37898345 |
| 19 | MP0001486_abnormal_startle_reflex | 2.36344420 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.36298314 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.30991169 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.24058270 |
| 23 | MP0001984_abnormal_olfaction | 2.21309719 |
| 24 | MP0002184_abnormal_innervation | 2.15980267 |
| 25 | MP0000778_abnormal_nervous_system | 2.15816608 |
| 26 | MP0002067_abnormal_sensory_capabilities | 2.06205555 |
| 27 | MP0005645_abnormal_hypothalamus_physiol | 2.06093378 |
| 28 | MP0004924_abnormal_behavior | 2.02072133 |
| 29 | MP0005386_behavior/neurological_phenoty | 2.02072133 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 1.96057270 |
| 31 | MP0002733_abnormal_thermal_nociception | 1.92672907 |
| 32 | MP0001188_hyperpigmentation | 1.91799480 |
| 33 | MP0004142_abnormal_muscle_tone | 1.91454386 |
| 34 | MP0008877_abnormal_DNA_methylation | 1.89125092 |
| 35 | MP0002557_abnormal_social/conspecific_i | 1.86709140 |
| 36 | MP0001970_abnormal_pain_threshold | 1.83805307 |
| 37 | MP0002822_catalepsy | 1.77832848 |
| 38 | MP0001502_abnormal_circadian_rhythm | 1.48934999 |
| 39 | MP0005551_abnormal_eye_electrophysiolog | 1.44202016 |
| 40 | MP0010386_abnormal_urinary_bladder | 1.42248867 |
| 41 | MP0000751_myopathy | 1.41444179 |
| 42 | MP0003879_abnormal_hair_cell | 1.41378649 |
| 43 | MP0002638_abnormal_pupillary_reflex | 1.39553669 |
| 44 | MP0005646_abnormal_pituitary_gland | 1.38360205 |
| 45 | MP0004742_abnormal_vestibular_system | 1.37142494 |
| 46 | MP0001986_abnormal_taste_sensitivity | 1.35603326 |
| 47 | MP0002882_abnormal_neuron_morphology | 1.34841099 |
| 48 | MP0002909_abnormal_adrenal_gland | 1.33053417 |
| 49 | MP0004811_abnormal_neuron_physiology | 1.32849118 |
| 50 | MP0009379_abnormal_foot_pigmentation | 1.31388216 |
| 51 | MP0006072_abnormal_retinal_apoptosis | 1.31262122 |
| 52 | MP0002066_abnormal_motor_capabilities/c | 1.29897539 |
| 53 | MP0000631_abnormal_neuroendocrine_gland | 1.28976868 |
| 54 | MP0002102_abnormal_ear_morphology | 1.27062289 |
| 55 | MP0000955_abnormal_spinal_cord | 1.25038204 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.16581837 |
| 57 | MP0003329_amyloid_beta_deposits | 1.14076321 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.10197069 |
| 59 | MP0008569_lethality_at_weaning | 1.09100942 |
| 60 | MP0002152_abnormal_brain_morphology | 1.07057210 |
| 61 | MP0002752_abnormal_somatic_nervous | 1.06562296 |
| 62 | MP0005409_darkened_coat_color | 1.05270927 |
| 63 | MP0008872_abnormal_physiological_respon | 1.05196066 |
| 64 | MP0001963_abnormal_hearing_physiology | 1.02631491 |
| 65 | MP0005394_taste/olfaction_phenotype | 1.02619875 |
| 66 | MP0005499_abnormal_olfactory_system | 1.02619875 |
| 67 | MP0003121_genomic_imprinting | 0.98828920 |
| 68 | MP0002751_abnormal_autonomic_nervous | 0.98420677 |
| 69 | MP0004133_heterotaxia | 0.96595707 |
| 70 | MP0006035_abnormal_mitochondrial_morpho | 0.95893847 |
| 71 | MP0000538_abnormal_urinary_bladder | 0.95562506 |
| 72 | MP0005535_abnormal_body_temperature | 0.95317487 |
| 73 | MP0002229_neurodegeneration | 0.93691985 |
| 74 | MP0002090_abnormal_vision | 0.93102115 |
| 75 | MP0004085_abnormal_heartbeat | 0.92327742 |
| 76 | MP0003011_delayed_dark_adaptation | 0.91695019 |
| 77 | MP0003890_abnormal_embryonic-extraembry | 0.91266302 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 0.90978275 |
| 79 | MP0002069_abnormal_eating/drinking_beha | 0.88123712 |
| 80 | MP0000026_abnormal_inner_ear | 0.86152403 |
| 81 | MP0004145_abnormal_muscle_electrophysio | 0.85664076 |
| 82 | MP0004043_abnormal_pH_regulation | 0.84996402 |
| 83 | MP0001664_abnormal_digestion | 0.84883262 |
| 84 | MP0003787_abnormal_imprinting | 0.84575761 |
| 85 | MP0002163_abnormal_gland_morphology | 0.83576690 |
| 86 | MP0000049_abnormal_middle_ear | 0.82135036 |
| 87 | MP0001727_abnormal_embryo_implantation | 0.81047519 |
| 88 | MP0000569_abnormal_digit_pigmentation | 0.79971520 |
| 89 | MP0006292_abnormal_olfactory_placode | 0.79520543 |
| 90 | MP0008789_abnormal_olfactory_epithelium | 0.77676962 |
| 91 | MP0002234_abnormal_pharynx_morphology | 0.76689424 |
| 92 | MP0005253_abnormal_eye_physiology | 0.75873240 |
| 93 | MP0003137_abnormal_impulse_conducting | 0.75392129 |
| 94 | MP0005084_abnormal_gallbladder_morpholo | 0.74835373 |
| 95 | MP0001299_abnormal_eye_distance/ | 0.74783977 |
| 96 | MP0000566_synostosis | 0.73260699 |
| 97 | MP0004858_abnormal_nervous_system | 0.71573527 |
| 98 | MP0008995_early_reproductive_senescence | 0.70936022 |
| 99 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70170887 |
| 100 | MP0004215_abnormal_myocardial_fiber | 0.69827798 |
| 101 | MP0001943_abnormal_respiration | 0.69783819 |
| 102 | MP0002653_abnormal_ependyma_morphology | 0.69532048 |
| 103 | MP0003315_abnormal_perineum_morphology | 0.69419891 |
| 104 | MP0003119_abnormal_digestive_system | 0.67231842 |
| 105 | MP0003631_nervous_system_phenotype | 0.66574100 |
| 106 | MP0008875_abnormal_xenobiotic_pharmacok | 0.65058604 |
| 107 | MP0004147_increased_porphyrin_level | 0.64827004 |
| 108 | MP0003938_abnormal_ear_development | 0.64328304 |
| 109 | MP0003634_abnormal_glial_cell | 0.64147419 |
| 110 | MP0003195_calcinosis | 0.63976659 |
| 111 | MP0009780_abnormal_chondrocyte_physiolo | 0.62054185 |
| 112 | MP0000647_abnormal_sebaceous_gland | 0.61901434 |
| 113 | MP0000372_irregular_coat_pigmentation | 0.61860051 |
| 114 | MP0002928_abnormal_bile_duct | 0.61554075 |
| 115 | MP0003861_abnormal_nervous_system | 0.61047625 |
| 116 | MP0003633_abnormal_nervous_system | 0.60611618 |
| 117 | MP0005195_abnormal_posterior_eye | 0.60438984 |
| 118 | MP0004885_abnormal_endolymph | 0.59229351 |
| 119 | MP0005187_abnormal_penis_morphology | 0.56491037 |
| 120 | MP0001485_abnormal_pinna_reflex | 0.55281082 |
| 121 | MP0003632_abnormal_nervous_system | 0.52638146 |
| 122 | MP0010770_preweaning_lethality | 0.52372857 |
| 123 | MP0002082_postnatal_lethality | 0.52372857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.60339741 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 5.22661904 |
| 3 | Limb dystonia (HP:0002451) | 5.01778387 |
| 4 | Progressive macrocephaly (HP:0004481) | 4.67881511 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.63004821 |
| 6 | Atonic seizures (HP:0010819) | 4.46094650 |
| 7 | Focal seizures (HP:0007359) | 4.35004419 |
| 8 | Myokymia (HP:0002411) | 4.23687864 |
| 9 | Mitochondrial inheritance (HP:0001427) | 4.11685175 |
| 10 | Acute encephalopathy (HP:0006846) | 4.04067379 |
| 11 | Epileptic encephalopathy (HP:0200134) | 4.03591990 |
| 12 | Absence seizures (HP:0002121) | 4.01831698 |
| 13 | Visual hallucinations (HP:0002367) | 3.92048756 |
| 14 | Febrile seizures (HP:0002373) | 3.91067475 |
| 15 | Polyphagia (HP:0002591) | 3.76632913 |
| 16 | Dialeptic seizures (HP:0011146) | 3.62755814 |
| 17 | Abnormal hair whorl (HP:0010721) | 3.58897257 |
| 18 | Lissencephaly (HP:0001339) | 3.32928857 |
| 19 | Failure to thrive in infancy (HP:0001531) | 3.30639894 |
| 20 | Generalized tonic-clonic seizures (HP:0002069) | 3.27230869 |
| 21 | Broad-based gait (HP:0002136) | 3.27140534 |
| 22 | Hyperventilation (HP:0002883) | 3.26068883 |
| 23 | Increased CSF lactate (HP:0002490) | 3.25108288 |
| 24 | Progressive cerebellar ataxia (HP:0002073) | 3.23484614 |
| 25 | Amblyopia (HP:0000646) | 3.04291882 |
| 26 | Optic disc pallor (HP:0000543) | 3.02193982 |
| 27 | Gait imbalance (HP:0002141) | 3.00928281 |
| 28 | Pachygyria (HP:0001302) | 2.99352861 |
| 29 | Retinal dysplasia (HP:0007973) | 2.95768314 |
| 30 | Pheochromocytoma (HP:0002666) | 2.93528033 |
| 31 | Increased hepatocellular lipid droplets (HP:0006565) | 2.91828503 |
| 32 | Medial flaring of the eyebrow (HP:0010747) | 2.90226576 |
| 33 | Urinary urgency (HP:0000012) | 2.87248261 |
| 34 | Abnormality of midbrain morphology (HP:0002418) | 2.86653301 |
| 35 | Molar tooth sign on MRI (HP:0002419) | 2.86653301 |
| 36 | Hepatocellular necrosis (HP:0001404) | 2.84007284 |
| 37 | Neuroendocrine neoplasm (HP:0100634) | 2.82664144 |
| 38 | Abnormal eating behavior (HP:0100738) | 2.74685655 |
| 39 | Esotropia (HP:0000565) | 2.64129039 |
| 40 | Hypoventilation (HP:0002791) | 2.61828287 |
| 41 | Congenital primary aphakia (HP:0007707) | 2.61749061 |
| 42 | Abnormal pupillary function (HP:0007686) | 2.61137519 |
| 43 | Renal Fanconi syndrome (HP:0001994) | 2.58812641 |
| 44 | Progressive inability to walk (HP:0002505) | 2.57877111 |
| 45 | Poor suck (HP:0002033) | 2.54038069 |
| 46 | Anxiety (HP:0000739) | 2.51106327 |
| 47 | Pancreatic fibrosis (HP:0100732) | 2.50791397 |
| 48 | Cerebral edema (HP:0002181) | 2.50137290 |
| 49 | Leukodystrophy (HP:0002415) | 2.50100203 |
| 50 | Drooling (HP:0002307) | 2.48052761 |
| 51 | Excessive salivation (HP:0003781) | 2.48052761 |
| 52 | Nephrogenic diabetes insipidus (HP:0009806) | 2.45090799 |
| 53 | Nephronophthisis (HP:0000090) | 2.43281803 |
| 54 | Spastic tetraplegia (HP:0002510) | 2.42040920 |
| 55 | True hermaphroditism (HP:0010459) | 2.41474419 |
| 56 | Pancreatic cysts (HP:0001737) | 2.40704483 |
| 57 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.40465746 |
| 58 | Truncal ataxia (HP:0002078) | 2.40401577 |
| 59 | Hypothermia (HP:0002045) | 2.39913898 |
| 60 | Amyotrophic lateral sclerosis (HP:0007354) | 2.38551754 |
| 61 | Epileptiform EEG discharges (HP:0011182) | 2.38278956 |
| 62 | Type II lissencephaly (HP:0007260) | 2.37462548 |
| 63 | Lipid accumulation in hepatocytes (HP:0006561) | 2.37302586 |
| 64 | Abnormal ciliary motility (HP:0012262) | 2.34792153 |
| 65 | Genital tract atresia (HP:0001827) | 2.33987681 |
| 66 | Agitation (HP:0000713) | 2.33126959 |
| 67 | Vaginal atresia (HP:0000148) | 2.31441052 |
| 68 | Chronic hepatic failure (HP:0100626) | 2.31392166 |
| 69 | EEG with generalized epileptiform discharges (HP:0011198) | 2.30646364 |
| 70 | Exotropia (HP:0000577) | 2.30609990 |
| 71 | Specific learning disability (HP:0001328) | 2.30165646 |
| 72 | Status epilepticus (HP:0002133) | 2.25588987 |
| 73 | Abnormality of the labia minora (HP:0012880) | 2.24774362 |
| 74 | X-linked dominant inheritance (HP:0001423) | 2.22523289 |
| 75 | Delayed gross motor development (HP:0002194) | 2.21114362 |
| 76 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.20584375 |
| 77 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.20584375 |
| 78 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.17209538 |
| 79 | Absent/shortened dynein arms (HP:0200106) | 2.17209538 |
| 80 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.16744814 |
| 81 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.15739274 |
| 82 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.15739274 |
| 83 | Exercise intolerance (HP:0003546) | 2.14005366 |
| 84 | Cerebral inclusion bodies (HP:0100314) | 2.13283939 |
| 85 | Poor coordination (HP:0002370) | 2.13164824 |
| 86 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.12384525 |
| 87 | Inability to walk (HP:0002540) | 2.11671683 |
| 88 | Narrow nasal bridge (HP:0000446) | 2.10084817 |
| 89 | Renal cortical cysts (HP:0000803) | 2.09084832 |
| 90 | Gaze-evoked nystagmus (HP:0000640) | 2.09038401 |
| 91 | Hemiparesis (HP:0001269) | 2.08441541 |
| 92 | Abnormality of the corticospinal tract (HP:0002492) | 2.07456221 |
| 93 | Decreased circulating renin level (HP:0003351) | 2.06720096 |
| 94 | Oligomenorrhea (HP:0000876) | 2.05835568 |
| 95 | Hypsarrhythmia (HP:0002521) | 2.05632229 |
| 96 | Protruding tongue (HP:0010808) | 2.04149994 |
| 97 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.03755997 |
| 98 | Hypoplasia of the brainstem (HP:0002365) | 2.03755997 |
| 99 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.03570805 |
| 100 | Insidious onset (HP:0003587) | 2.03526176 |
| 101 | Termporal pattern (HP:0011008) | 2.03526176 |
| 102 | Muscular hypotonia of the trunk (HP:0008936) | 2.02841284 |
| 103 | Increased serum pyruvate (HP:0003542) | 2.01513610 |
| 104 | Abnormality of glycolysis (HP:0004366) | 2.01513610 |
| 105 | Methylmalonic acidemia (HP:0002912) | 1.97167264 |
| 106 | Pendular nystagmus (HP:0012043) | 1.96948897 |
| 107 | Delusions (HP:0000746) | 1.96151033 |
| 108 | Ankle clonus (HP:0011448) | 1.95631526 |
| 109 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.94730817 |
| 110 | Cortical dysplasia (HP:0002539) | 1.92866122 |
| 111 | Respiratory failure (HP:0002878) | 1.92583069 |
| 112 | Psychosis (HP:0000709) | 1.91991649 |
| 113 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.91126283 |
| 114 | Increased intramyocellular lipid droplets (HP:0012240) | 1.88989352 |
| 115 | Sleep apnea (HP:0010535) | 1.87492196 |
| 116 | Abnormality of the renal medulla (HP:0100957) | 1.87417394 |
| 117 | Supranuclear gaze palsy (HP:0000605) | 1.86126289 |
| 118 | Fetal akinesia sequence (HP:0001989) | 1.83333695 |
| 119 | Spastic gait (HP:0002064) | 1.83267084 |
| 120 | Lactic acidosis (HP:0003128) | 1.83049553 |
| 121 | Mutism (HP:0002300) | 1.82542465 |
| 122 | Decreased testicular size (HP:0008734) | 1.80871546 |
| 123 | Abnormality of the renal cortex (HP:0011035) | 1.80794683 |
| 124 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.79561081 |
| 125 | Polymicrogyria (HP:0002126) | 1.79483855 |
| 126 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.79371495 |
| 127 | Ulnar claw (HP:0001178) | 1.79327238 |
| 128 | Poor eye contact (HP:0000817) | 1.78960036 |
| 129 | Postaxial hand polydactyly (HP:0001162) | 1.78501956 |
| 130 | Absent speech (HP:0001344) | 1.78444843 |
| 131 | Hyperthyroidism (HP:0000836) | 1.76558721 |
| 132 | Intellectual disability, severe (HP:0010864) | 1.76214702 |
| 133 | Scrotal hypoplasia (HP:0000046) | 1.75245416 |
| 134 | Dysdiadochokinesis (HP:0002075) | 1.74552436 |
| 135 | Generalized myoclonic seizures (HP:0002123) | 1.73665227 |
| 136 | Thyroid-stimulating hormone excess (HP:0002925) | 1.72901287 |
| 137 | Anencephaly (HP:0002323) | 1.70721671 |
| 138 | 3-Methylglutaconic aciduria (HP:0003535) | 1.70325305 |
| 139 | Cupped ear (HP:0000378) | 1.70280589 |
| 140 | Genetic anticipation (HP:0003743) | 1.70129811 |
| 141 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.69393353 |
| 142 | Patellar aplasia (HP:0006443) | 1.68675819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 3.67036782 |
| 2 | NTRK3 | 3.63536152 |
| 3 | MARK1 | 3.58437945 |
| 4 | MAP3K12 | 3.55721149 |
| 5 | MAP3K4 | 3.40278603 |
| 6 | MAP4K2 | 3.06324394 |
| 7 | MAP2K7 | 3.04212372 |
| 8 | PNCK | 3.00223837 |
| 9 | MAP3K9 | 2.89312175 |
| 10 | NME1 | 2.54041310 |
| 11 | MINK1 | 2.29719685 |
| 12 | MAPK13 | 2.24001152 |
| 13 | EPHA4 | 2.23354585 |
| 14 | NTRK2 | 2.14557712 |
| 15 | WNK3 | 2.13148655 |
| 16 | TRIM28 | 2.02568446 |
| 17 | MAP2K4 | 2.00197176 |
| 18 | GRK5 | 1.96303686 |
| 19 | FRK | 1.87302638 |
| 20 | DYRK3 | 1.71336219 |
| 21 | ARAF | 1.70761325 |
| 22 | PLK2 | 1.67612602 |
| 23 | UHMK1 | 1.58689091 |
| 24 | CDK19 | 1.47098221 |
| 25 | SIK2 | 1.45647382 |
| 26 | TNIK | 1.43424875 |
| 27 | GRK7 | 1.42116652 |
| 28 | RIPK4 | 1.35237895 |
| 29 | PINK1 | 1.31998526 |
| 30 | CAMK2A | 1.30836396 |
| 31 | BMPR1B | 1.20376164 |
| 32 | CDK5 | 1.19495198 |
| 33 | OXSR1 | 1.17689185 |
| 34 | CAMK2B | 1.17324257 |
| 35 | CAMKK2 | 1.16899980 |
| 36 | FGR | 1.16257575 |
| 37 | BCR | 1.16032873 |
| 38 | CSNK1G3 | 1.14752138 |
| 39 | KSR1 | 1.12833421 |
| 40 | CSNK1G2 | 1.10792872 |
| 41 | CAMK1G | 1.06474342 |
| 42 | DAPK2 | 1.06466374 |
| 43 | SIK3 | 1.03765837 |
| 44 | PRKCG | 1.03606962 |
| 45 | ADRBK1 | 1.02252791 |
| 46 | DAPK1 | 1.01969863 |
| 47 | DYRK2 | 1.01825380 |
| 48 | STK16 | 1.01349524 |
| 49 | MAPKAPK5 | 1.00739936 |
| 50 | DYRK1A | 1.00259112 |
| 51 | PAK6 | 0.98462646 |
| 52 | CDK18 | 0.98346464 |
| 53 | FES | 0.97416895 |
| 54 | CDK14 | 0.95733662 |
| 55 | ADRBK2 | 0.94792201 |
| 56 | CDK15 | 0.92637662 |
| 57 | EPHA3 | 0.90723857 |
| 58 | PHKG2 | 0.87864772 |
| 59 | PHKG1 | 0.87864772 |
| 60 | DYRK1B | 0.86940551 |
| 61 | PAK3 | 0.84640720 |
| 62 | CAMK2D | 0.84526722 |
| 63 | MYLK | 0.84263336 |
| 64 | WNK4 | 0.83645582 |
| 65 | STK39 | 0.81118729 |
| 66 | CDK11A | 0.80868197 |
| 67 | BMPR2 | 0.77713259 |
| 68 | RPS6KA4 | 0.75305127 |
| 69 | TAOK1 | 0.72754503 |
| 70 | PRKCE | 0.72463234 |
| 71 | SGK2 | 0.71268805 |
| 72 | PTK2B | 0.69150344 |
| 73 | GRK6 | 0.68338099 |
| 74 | GRK1 | 0.68071316 |
| 75 | INSRR | 0.67626066 |
| 76 | NTRK1 | 0.66994192 |
| 77 | CSNK1G1 | 0.65550395 |
| 78 | LATS2 | 0.62999229 |
| 79 | MAPK15 | 0.62263312 |
| 80 | CAMK2G | 0.61838128 |
| 81 | EPHB2 | 0.61830202 |
| 82 | BRAF | 0.58824518 |
| 83 | MUSK | 0.57279118 |
| 84 | CSNK1D | 0.54387506 |
| 85 | TSSK6 | 0.52913444 |
| 86 | ERBB3 | 0.52496830 |
| 87 | SGK223 | 0.52491791 |
| 88 | SGK494 | 0.52491791 |
| 89 | MAP3K6 | 0.52156344 |
| 90 | STK11 | 0.51867101 |
| 91 | PKN1 | 0.51839213 |
| 92 | PRKACA | 0.51702475 |
| 93 | PRKCZ | 0.49536700 |
| 94 | ROCK2 | 0.49295103 |
| 95 | PRPF4B | 0.48947041 |
| 96 | AKT3 | 0.48218290 |
| 97 | CDK3 | 0.47070789 |
| 98 | PRKAA1 | 0.45489547 |
| 99 | SRPK1 | 0.44588376 |
| 100 | PRKACB | 0.43778371 |
| 101 | MAP3K13 | 0.43727049 |
| 102 | CAMK1 | 0.43586684 |
| 103 | LIMK1 | 0.43027487 |
| 104 | CSNK1A1L | 0.42779423 |
| 105 | MAPK4 | 0.42455137 |
| 106 | RPS6KA5 | 0.41957223 |
| 107 | FGFR2 | 0.41069381 |
| 108 | CSNK1A1 | 0.39513269 |
| 109 | SGK1 | 0.38846853 |
| 110 | MARK2 | 0.37627086 |
| 111 | MAPK9 | 0.35918666 |
| 112 | CAMK4 | 0.35668919 |
| 113 | CCNB1 | 0.35246119 |
| 114 | PRKCA | 0.34182913 |
| 115 | FER | 0.34141419 |
| 116 | RPS6KA3 | 0.33785144 |
| 117 | CAMKK1 | 0.33236735 |
| 118 | CAMK1D | 0.32813263 |
| 119 | PLK3 | 0.32763483 |
| 120 | PRKCB | 0.32594997 |
| 121 | TNK2 | 0.31597153 |
| 122 | CSNK1E | 0.31554527 |
| 123 | PRKG1 | 0.31039279 |
| 124 | KSR2 | 0.30317946 |
| 125 | PRKACG | 0.30299675 |
| 126 | RPS6KA2 | 0.29643508 |
| 127 | TAOK3 | 0.27870619 |
| 128 | MAPK8 | 0.27340127 |
| 129 | PDK2 | 0.26629434 |
| 130 | MKNK2 | 0.25875003 |
| 131 | EGFR | 0.24767018 |
| 132 | YES1 | 0.24541850 |
| 133 | TESK1 | 0.24482710 |
| 134 | GSK3B | 0.22538084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.48124436 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.41642618 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.71750117 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.33076294 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 3.03543669 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.93468631 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75884717 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.59822467 |
| 9 | Huntingtons disease_Homo sapiens_hsa05016 | 2.56371002 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.43138713 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.27783489 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.05613703 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.04635964 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.04417884 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 2.03852446 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.02398641 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 2.01510342 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.01293949 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.00216630 |
| 20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.78018001 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.77841662 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.77630109 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.62187000 |
| 24 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.59793538 |
| 25 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.57320586 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.55579453 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54445878 |
| 28 | Insulin secretion_Homo sapiens_hsa04911 | 1.50629822 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.48110997 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.45009097 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.35299509 |
| 32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.31533908 |
| 33 | Phototransduction_Homo sapiens_hsa04744 | 1.27347199 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.27145728 |
| 35 | Basal transcription factors_Homo sapiens_hsa03022 | 1.25044251 |
| 36 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.22997962 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.21475847 |
| 38 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.16441892 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.15748940 |
| 40 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.12705916 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.11086933 |
| 42 | Gap junction_Homo sapiens_hsa04540 | 1.10723557 |
| 43 | Axon guidance_Homo sapiens_hsa04360 | 1.10494224 |
| 44 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.10351811 |
| 45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.97821953 |
| 46 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95559640 |
| 47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.90698747 |
| 48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87173994 |
| 49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84951001 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83826130 |
| 51 | Proteasome_Homo sapiens_hsa03050 | 0.82696459 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73549759 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.67970234 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.66890971 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66361574 |
| 56 | Alcoholism_Homo sapiens_hsa05034 | 0.65802635 |
| 57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63611445 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63192758 |
| 59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.62315805 |
| 60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.60386820 |
| 61 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59017081 |
| 62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.58159894 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57036083 |
| 64 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56720879 |
| 65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.56674611 |
| 66 | Ribosome_Homo sapiens_hsa03010 | 0.56478321 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.56350331 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55938371 |
| 69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55511844 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54325377 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.54030080 |
| 72 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.53936252 |
| 73 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.53401902 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53014348 |
| 75 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49587401 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46526530 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46498627 |
| 78 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.46486870 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45143194 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42986264 |
| 81 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.41793265 |
| 82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41730423 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41322916 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40999347 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40349194 |
| 86 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40136550 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39502889 |
| 88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.38884836 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36730101 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.36648655 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.36014302 |
| 92 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35358811 |
| 93 | Peroxisome_Homo sapiens_hsa04146 | 0.34888808 |
| 94 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.34685358 |
| 95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34052114 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.33047479 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32878754 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.32783644 |
| 99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.32311556 |
| 100 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32028536 |
| 101 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31825912 |
| 102 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.31814524 |
| 103 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.31091628 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.30672916 |
| 105 | Protein export_Homo sapiens_hsa03060 | 0.30543033 |
| 106 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.29329749 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28566530 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.28528655 |
| 109 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.26505299 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25851440 |
| 111 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.25193050 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24931769 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24319638 |
| 114 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.24056027 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21672803 |
| 116 | RNA degradation_Homo sapiens_hsa03018 | 0.21000084 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18114224 |
| 118 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.17877204 |
| 119 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.17824524 |
| 120 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.17235599 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.17019030 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.16628259 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.15282035 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.14539514 |
| 125 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.13178859 |
| 126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.11793296 |
| 127 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.10505942 |

